Offer - Urjas Oil for just ₹ 1 X
Pamorelin LA 3.75 Injection is a commercial drug that is prescribed in the form of Injection. Prostate Cancer are some of its major therapeutic uses. The alternative uses of Pamorelin LA 3.75 Injection have also been explained below.
The right dosage of Pamorelin LA 3.75 Injection depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Pamorelin LA 3.75 Injection also has some side effects, the most common being Excessive sweating, Paresthesia. While these are the most often observed Pamorelin LA 3.75 Injection side effects, there are can be others also. These have been listed below. Usually, these side effects of Pamorelin LA 3.75 Injection go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Pamorelin LA 3.75 Injection's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Pamorelin LA 3.75 Injection's effects on the liver, heart and kidney are discussed below in the Pamorelin LA 3.75 Injection related warnings section.
Some other conditions that can be affected by Pamorelin LA 3.75 Injection are listed in the contraindications section below.
Drug interactions for Pamorelin LA 3.75 Injection have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Pamorelin LA 3.75 Injection is not safe while driving, and is is not addictive in nature.
Pamorelin LA 3.75 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Male) |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Pamorelin LA 3.75 Injection safe for pregnant women?
Pamorelin LA has many dangerous side effects in pregnant women. If you are pregnant, do not consume Pamorelin LA without medical advice.
Is the use of Pamorelin LA 3.75 Injection safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Pamorelin LA. So it is adviced to consult the doctor before using it.
What is the effect of Pamorelin LA 3.75 Injection on the Kidneys?
Pamorelin LA rarely harms the kidneys.
What is the effect of Pamorelin LA 3.75 Injection on the Liver?
Side effects of Pamorelin LA rarely affect the liver.
What is the effect of Pamorelin LA 3.75 Injection on the Heart?
Use of Pamorelin LA may be dangerous for the heart. Do not use it without doctor's advice.
Pamorelin LA 3.75 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Pamorelin LA 3.75 Injection unless your doctor advises you to do so -
Is this Pamorelin LA 3.75 Injection habit forming or addictive?
Pamorelin LA 3.75 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Pamorelin LA 3.75 Injection. So it is best to avoid driving.
Is it safe?
Yes, but consume Pamorelin LA 3.75 Injection only on doctor's advice.
Is it able to treat mental disorders?
No, Pamorelin LA 3.75 Injection is not used to treat mental disorders.
Interaction between Food and Pamorelin LA 3.75 Injection
Due to the absence of research, it is difficult to say how Pamorelin LA 3.75 Injection and food will interact.
Interaction between Alcohol and Pamorelin LA 3.75 Injection
Information about the interaction of Pamorelin LA 3.75 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 53
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 242-243
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trelstar® (triptorelin pamoate)